209 related articles for article (PubMed ID: 11593306)
1. Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease.
Gonçalves MS; Queiroz IL; Cardoso SA; Zanetti A; Strapazoni AC; Adorno E; Albuquerque A; Sant'Ana A; dos Reis MG; Barral A; Barral Netto M
Braz J Med Biol Res; 2001 Oct; 34(10):1309-13. PubMed ID: 11593306
[TBL] [Abstract][Full Text] [Related]
2. Elevated IL-8 levels during sickle cell crisis.
Duits AJ; Schnog JB; Lard LR; Saleh AW; Rojer RA
Eur J Haematol; 1998 Nov; 61(5):302-5. PubMed ID: 9855244
[TBL] [Abstract][Full Text] [Related]
3. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition.
Sarray S; Saleh LR; Lisa Saldanha F; Al-Habboubi HH; Mahdi N; Almawi WY
Cytokine; 2015 Mar; 72(1):43-7. PubMed ID: 25569375
[TBL] [Abstract][Full Text] [Related]
4. Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.
Musa BO; Onyemelukwe GC; Hambolu JO; Mamman AI; Isa AH
Clin Vaccine Immunol; 2010 Apr; 17(4):602-8. PubMed ID: 20130127
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of reticulated platelets in patients with sickle cell diseases.
Noronha JF; Costa FF; Saad ST; Lorand-Metze IG; Grotto HZ
Thromb Res; 2007; 121(2):259-67. PubMed ID: 17521711
[TBL] [Abstract][Full Text] [Related]
6. Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisis.
Nahavandi M; Tavakkoli F; Wyche MQ; Perlin E; Millis RM
Hematology; 2003 Dec; 8(6):421-8. PubMed ID: 14668039
[TBL] [Abstract][Full Text] [Related]
7. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.
Morris CR; Kuypers FA; Larkin S; Vichinsky EP; Styles LA
J Pediatr Hematol Oncol; 2000; 22(6):515-20. PubMed ID: 11132219
[TBL] [Abstract][Full Text] [Related]
8. Association between plasma free haem and incidence of vaso-occlusive episodes and acute chest syndrome in children with sickle cell disease.
Adisa OA; Hu Y; Ghosh S; Aryee D; Osunkwo I; Ofori-Acquah SF
Br J Haematol; 2013 Sep; 162(5):702-5. PubMed ID: 23802701
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis.
Michaels LA; Ohene-Frempong K; Zhao H; Douglas SD
Blood; 1998 Nov; 92(9):3148-51. PubMed ID: 9787150
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiological, clinical and hematological profiles of homozygous sickle cell disease during the intercritical period among children in Ziguinchor, Senegal].
Thiam L; Dramé A; Coly IZ; Diouf FN; Seck N; Boiro D; Ndongo AA; Basse I; Niang B; Deme/Ly I; Sylla A; Diagne I; Ndiaye O
Pan Afr Med J; 2017; 28():208. PubMed ID: 29610646
[TBL] [Abstract][Full Text] [Related]
11. The influence of foetal haemoglobin on the frequency of vaso-occlusive crisis in sickle cell anaemia patients.
Enosolease ME; Ejele OA; Awodu OA
Niger Postgrad Med J; 2005 Jun; 12(2):102-5. PubMed ID: 15997258
[TBL] [Abstract][Full Text] [Related]
12. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
[TBL] [Abstract][Full Text] [Related]
13. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
Elshazly SA; Heiba NM; Abdelmageed WM
Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
[TBL] [Abstract][Full Text] [Related]
14. Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial.
Badaki-Makun O; Scott JP; Panepinto JA; Casper TC; Hillery CA; Dean JM; Brousseau DC;
Pediatr Blood Cancer; 2014 Jun; 61(6):1049-54. PubMed ID: 24443249
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications.
Tantawy AA; Adly AA; Ismail EA
Blood Coagul Fibrinolysis; 2012 Oct; 23(7):640-8. PubMed ID: 22885767
[TBL] [Abstract][Full Text] [Related]
16. Immunological Hallmarks of Inflammatory Status in Vaso-Occlusive Crisis of Sickle Cell Anemia Patients.
Silva-Junior AL; Garcia NP; Cardoso EC; Dias S; Tarragô AM; Fraiji NA; Gomes MS; Amaral LR; Teixeira-Carvalho A; Martins-Filho OA; De Paula EV; Costa AG; Malheiro A
Front Immunol; 2021; 12():559925. PubMed ID: 33776989
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of assessment of thrombospondin and placenta growth factor levels in patients with sickle cell anemia: two centers egyptian studies.
Hagag AA; Elmashad G; Abd El-Lateef AE
Mediterr J Hematol Infect Dis; 2014; 6(1):e2014044. PubMed ID: 25045452
[TBL] [Abstract][Full Text] [Related]
18. Eicosanoids in sickle cell disease: potential relevance of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid to the pathophysiology of vaso-occlusion.
Setty BN; Chen D; O'Neal P; Littrell JB; Grossman MH; Stuart MJ
J Lab Clin Med; 1998 Apr; 131(4):344-53. PubMed ID: 9579388
[TBL] [Abstract][Full Text] [Related]
19. Acute chest syndrome among children hospitalized with vaso-occlusive crisis: A nationwide study in the United States.
Takahashi T; Okubo Y; Handa A
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29134776
[TBL] [Abstract][Full Text] [Related]
20. Human platelet alloantigens (HPA) 1, HPA2, HPA3, HPA4, and HPA5 polymorphisms in sickle cell anemia patients with vaso-occlusive crisis.
Al-Subaie AM; Fawaz NA; Mahdi N; Al-Absi IK; Al-Ola K; Ameen G; Almawi WY
Eur J Haematol; 2009 Dec; 83(6):579-85. PubMed ID: 19702628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
